Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.

R, Nagarakanti; MD, Ezekowitz; J, Oldgren; S, Yang; M, Chernick; TH, Aikens; G, Flaker; J, Brugada; G, Kamensky; A, Parekh; PA, Reilly; S, Yusuf; SJ, Connolly

doi:10.1161/circulationaha.110.977546

Public

Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.

Shared by NobleBlocks on Jan 3, 2011 • 12:00 AM UTC

Authors:

Nagarakanti R

Ezekowitz MD

Oldgren J

Abstract

Background The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial compared dabigatran 110 mg BID (D110) and 150 mg BID (D150) with warfarin for stroke prevention in 18 113 patients with nonvalvular atrial fibrillation.Methods and results Cardioversion on randomized treatment wa...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!